Foam Sclerotherapy: A Textbook

John J Bergan MD FACS FRCS (Hon) Vein Institute of La Jolla, CA and Department of Surgery, UCSD School of Medicine, La Jolla, CA, USA Van Le Cheng MD UCSD Instructor of Surgery, SD Vein Institute, Encinitas, CA, USA

Contributing authors
Foreword 1
Foreword 2
Preface
THEORY
1. The history of sclerosant foams: persons, techniques, patents and medical improvements
2. Dermatological manifestations of venous insufficiency
3. Sclerotherapy of varicose veins — Guidelines of the German Society of Phlebology
4. Legal guidelines for use of polidocanol and sodium tetradecyl sulfate for sclerotherapy
PRACTICE
5. The science of producing extemporary foam and its clinical results
6. Ultrasound guidance for therapeutic interventions
7. A personal method for foam sclerotherapy: technique and results
8. Foam sclerotherapy with and without duplex ultrasound guidance
9. Foam sclerotherapy for varicose veins: medium-term results as assessed by ultrasound
SPECIAL CONSIDERATIONS
10. Varisolve® polidocanol microfoam compared with surgery or sclerotherapy in the management of varicose veins in the presence of trunk vein incompetence: European randomized controlled trial
11. Ultrasound-guided foam sclerotherapy of large varicose veins
12. Transition from alcohol to foam sclerotherapy for localized venous malformations with high risk
13. Treatment of telangiectasias by sclerosing foam
14. Comparison of polidocanol and sodium tetradecyl sulfate in the treatment of varicose and telangiectatic leg veins
15. Lesser importance of the saphenous vein in varicose vein treatment
16. Efficacy of polidocanol foam compared with polidocanol liquid in sclerotherapy of venous insufficiency
17. Studies on safety of foam sclerotherapy
18. Treatment of recurrent varicose veins by sclerosant foam
19. Vascular malformations
20. Treatment of venous malformations, Klippel–Trenaunay syndrome and other low-flow lesions with foamed sclerosants
Epilogue
Index